OCP Pretreatment in PCOS Patients Undergoing ICSI Using Antagonist Protocol
NCT03881904
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
740
Enrollment
OTHER
Sponsor class
Conditions
Subfertility, Female
Interventions
DRUG:
0.075mg gestodene/0.03mg ethinylestradiol
Sponsor
Ain Shams University